Priority Review to Multiple Myeloma, Lung Cancer Drugs Highlights Specialty Pharmacy Week in Review

Top stories of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/priority-review-to-multiple-myeloma-lung-cancer-dr" target="_blank">View the story "Priority Review to Multiple Myeloma, Lung Cancer Drugs Highlights Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
Mammogram scans | Image credit: okrasiuk - stock.adobe.com
Related Content

Developing a Limited Distribution Plan for Oral Oncology Products

March 21st 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Affordability of Orphan Drugs Hinges on Global Collaboration

March 6th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

FDA Approves Sarilumab for Adults With Polymyalgia Rheumatica

March 1st 2023

New Set of Recommendations Can Help Pharmacy Practice Authors Pick Best Journal to Publish Research

February 28th 2023

Developing a Limited Distribution Plan for Oral Oncology Products

March 21st 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Affordability of Orphan Drugs Hinges on Global Collaboration

March 6th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

FDA Approves Sarilumab for Adults With Polymyalgia Rheumatica

March 1st 2023

New Set of Recommendations Can Help Pharmacy Practice Authors Pick Best Journal to Publish Research

February 28th 2023

Developing a Limited Distribution Plan for Oral Oncology Products

March 21st 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Affordability of Orphan Drugs Hinges on Global Collaboration

March 6th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

FDA Approves Sarilumab for Adults With Polymyalgia Rheumatica

March 1st 2023

New Set of Recommendations Can Help Pharmacy Practice Authors Pick Best Journal to Publish Research

February 28th 2023
© 2023 MJH Life Sciences

All rights reserved.